Skip to main
University-wide Navigation

The Synthesis Core engages in the synthesis of non-commercial agents, hit/lead discovery/development chemistries, medicinal chemistry and/or the modification (e.g., using suitable reactive tags, isotopes, fluorophores) of bioactive probes, drugs or natural products for target identification studies (in conjunction with the UK Proteomics Core). Small molecule hit/lead discovery and development synthetic projects also commonly rely on computational models/ADMET (Computational Core) and evaluative studies conducted by the Translational Core. The Synthesis Core is an affiliate of the UK COBRE for Molecular Medicine and operates under the directorship of Professor David Watt with a current staff of three Ph.D. level chemists.

Hit/Lead Optimization

  • Synthesis/design consultation
  • Synthesis of 10s to 100s of analogs for evaluative assays

De Novo Synthesis

  • Synthesis/design consultation
  • Synthesis of target molecules based upon computational and/or biochemical models

Probe Synthesis

  • Synthesis/design consultation
  • Synthesis of target probes based on existing SAR
  • Assistance with pull-down assays (w/UK Proteomics Core)

Scale-up Synthesis of Select Agents

  • Production of select test agents (≤250 mgs) via fermentation or synthesis

Representative Publications


The Synthesis Core welcomes inquiries from UK investigators with an interest in the application of organic synthesis, medicinal chemistry, and/or chemical biology approaches to facilitate on-going or emerging research projects. For more information and to request services, please contact us.

Contact Us

Recommended CPRI Acknowledgment

This work was supported by the Center for Pharmaceutical Research and Innovation (CPRI, NIH P20 GM130456) and the National Center for Advancing Translational Sciences (UL1 TR001998).

We respectfully acknowledge the Elders and Traditional Owners of the land on which our building stands, which is the traditional territory of the Osage, Shawnee, Cherokee, Adena, and Hopewell peoples.